ChemBriefGoldman Sachs Alternatives Acquires Control of Italian Medtech Firm Numantec
Goldman Sachs Alternatives agreed to acquire Italian medtech firm Numantec from White Bridge Investment for approximately €700 million. Numantec manufactures healthcare products and drug-delivery devi
reuters · 2026-07-27 04:47